Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors

por Ferris, Steven H, Farlow, Martin
Publicado 2013

Mild cognitive impairment: historical development and summary of research

por Golomb, James, Kluger, Alan, Ferris, Steven H
Publicado 2004

Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease

por Ferris, Steven H, Schmitt, Frederick A, Saxton, Judith, Richardson, Sharon, Mackell, Joan, Sun, Yijun, Xu, Yikang
Publicado 2011

White matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer's disease()

por Benitez, Andreana, Fieremans, Els, Jensen, Jens H., Falangola, Maria F., Tabesh, Ali, Ferris, Steven H., Helpern, Joseph A.
Publicado 2013

Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)

por Aisen, Paul S., Gauthier, Serge, Ferris, Steven H., Saumier, Daniel, Haine, Denis, Garceau, Denis, Duong, Anh, Suhy, Joyce, Oh, Joonmi, Lau, Wan C., Sampalis, John
Publicado 2011